Question 1

What are the main structural components of polymeric carriers?

Accepted Answer

Polymeric carriers consist of four key components: a biodegradable polymeric backbone that provides structural integrity, a homing device for molecular recognition and targeting, functional chains that enhance physicochemical properties like solubility, and a cleavable spacer that links the drug and enables controlled release. Common polymers include polyethyleneimine, polylysine, chitosan, dextran, and PEG.

Question 2

How do homing devices enable site-targeted drug delivery?

Accepted Answer

Homing devices are molecular recognition components, such as monoclonal antibodies or sugar moieties, that selectively bind to specific target tissues or cells. This targeted binding ensures precise drug localization at the intended site, enhancing the therapeutic index while minimizing off-target effects. This approach is particularly valuable in cancer therapy and gene therapy applications.

Question 3

Why do solubilizers improve drug delivery effectiveness?

Accepted Answer

Solubilizers enhance physicochemical properties by increasing aqueous solubility of hydrophobic drugs, allowing better dispersion and absorption. This modification improves bioavailability and prolongs systemic circulation time, enabling more effective drug transport and cellular uptake. Enhanced solubility is crucial for achieving therapeutic efficacy with poorly soluble compounds.

Question 4

What role does the cleavable spacer play in controlled drug release?

Accepted Answer

The cleavable spacer covalently links the drug to the polymeric backbone and facilitates controlled release through hydrolysis or enzymatic cleavage. This mechanism ensures sustained drug availability at the target site, reducing dosing frequency and minimizing side effects. The spacer's design determines the release kinetics and therapeutic outcome.

Question 5

How do nanoparticles improve drug delivery compared to microparticles?

Accepted Answer

Nanoparticles offer superior drug delivery advantages over microparticles by penetrating deeper into tissues due to their smaller size, improving drug distribution and cellular uptake. Both micro- and nanoparticles enhance drug stability and enable controlled release, but nanoparticles' enhanced tissue penetration makes them particularly effective for cancer therapy and reaching difficult-to-access cellular targets.

Question 6

What therapeutic applications benefit most from polymeric carrier systems?

Accepted Answer

Polymeric carriers are especially valuable for delivering proteins, peptides, and gene therapies, with significant applications in cancer therapy and controlled-release formulations. Their ability to provide site-targeted delivery while minimizing off-target effects makes them ideal for conditions requiring high specificity. Recent advancements continue to enhance precision medicine and targeted therapeutic approaches.

Question 7

Which polymers are commonly used in polymeric carrier systems?

Accepted Answer

Common polymers include polyethyleneimine, polylysine, chitosan, dextran, and PEG. These biodegradable polymers provide structural integrity, enhance drug stability, and ensure biocompatibility with biological systems. Their selection depends on the specific therapeutic application, target tissue, and desired release profile for optimal drug delivery performance.

표적 부위 약물 전달 시스템: 고분자 운반체